Techniques in Regional Anesthesia & Pain Management
Volume 13, Issue 1 , Pages 28-37, January 2009

Lifestyle changes, dietary restrictions, and nutraceuticals in migraine prevention

  • Frederick R. Taylor, MD, FAHS

      Affiliations

    • Corresponding Author InformationAddress reprint requests and correspondence: Frederick R. Taylor, MD, FAHS, Park-Nicollet Health Services, 6490 Excelsior Blvd E-500, Minneapolis, MN 55426

University of Minnesota School of Medicine and Park-Nicollet Health Services, Minneapolis, Minnesota

Migraineurs commonly identify sleep disturbance, stress events, and dietary substances as provokers for headache. The medical establishment universally recommends dietary restrictions while inconsistently addressing other causes. Before frequent headaches develop, sufferers need to minimize risks of headache progression through lifestyle changes. As headaches increase, both sufferer and practitioner begin to consider prevention, the type of which may differ. Both US Headache Consortium and American Migraine Prevalence and Prevention Study recommendations exist for introduction of drug prevention. Patients consider conventional prevention, but restrict their presumed substance triggers and use alternative therapies as well. Options available include alternative and complementary therapies, optimized lifestyles with changes as necessary, dietary and substance changes, and drug prevention with either conventional pharmacotherapeutics or nutraceuticals. This article discusses this practitioner's empiric recommendation for lifestyle changes and graded evidence for dietary changes and nutraceuticals in migraineurs. Alcohol, aspartame, nitrates, and monosodium glutamate are Grade B-rated dietary substances needing restriction, with MSG lacking data specific for migraine. No consensus yet exists on the hierarchy of efficacy for the nutraceuticals. Given the number of patients studied and data consistency or lack thereof regarding efficacy, Petadolex appears to have best proof followed by magnesium > feverfew (no commercially available MIG-99 forms) > riboflavin > coenzyme Q10 > thiotic acid.

Keywords: US Headache Consortium, AMPP, Behavioral headache management, Dietary triggers, Nutraceuticals, Evidence grading

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S1084-208X(09)00009-3

doi:10.1053/j.trap.2009.03.008

Techniques in Regional Anesthesia & Pain Management
Volume 13, Issue 1 , Pages 28-37, January 2009